Assessment of Lateral Geniculate Nucleus Atrophy with 3T MR Imaging and Correlation with Clinical Stage of Glaucoma
Authors:
- K.T. MuKMK.T. Mu
- J.P. QiJQJ.P. Qi
- C.Y. WangCWC.Y. Wang
- W.Z. ZhuWZW.Z. Zhu
- L.M. XiaLXL.M. Xia
- Z.Q. ChenZCZ.Q. Chen
- H. ZhangHZH. Zhang
- F. AiFAF. Ai
- J.N. MorelliJMJ.N. Morelli
Open Access
- 14 July 2011
- journal article
- research article
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 32 (7) , 1347-1353
Abstract
BACKGROUND AND PURPOSE: Although previous animal studies have shown structural changes in ocular hypertension such as atrophy of the LGN, such changes have not been thoroughly studied in human glaucoma patients nor correlation made with clinical stage. Our aim was to investigate prospectively LGN atrophy in patients with POAG using 3T MR imaging and correlation with the clinical stage of disease. MATERIALS AND METHODS: Twenty-six patients with known POAG and 26 age-matched healthy volunteers were included in this institutional review board−approved study. All subjects underwent imaging on a 3T MR imaging system with a PD and GM sequence. LGN height and volume were measured by 2 blinded neuroradiologists. Measurements were compared and correlated with clinical glaucoma severity as assessed by static threshold visual field parameters. RESULTS: Average maximum LGN height in patients with glaucoma on PD images was 4.36 ± 0.61 mm (right) and 4.31 ± 0.61 mm (left), significantly less (P < 10−3) than respective measurements of 5.05 ± 0.41 and 4.99 ± 0.41 mm in volunteers. With the GM sequences, such respective measurements were also less (P < 10−3) in patients with glaucoma (4.20 ± 0.71 mm right, 4.00 ± 0.85 mm left) versus respective measurements in volunteers (4.88 ± 0.51 mm right, 4.77 ± 0.47 mm left). Average LGN volumes in the patient group were 98.0 ± 27.2 mm3 (right) and 93.7 ± 25.8 mm3 (left) with the PD sequence versus respective measurements of 85.2 ± 27.1 and 80.5 ± 23.6 mm3 with the GM sequence. All height and volume measurements were greater in volunteers (P < 10−3). In the patient group, both maximum height and volume of the LGN with both sequences were significantly correlated with cumulative clinical glaucoma stage (P < .05). CONCLUSIONS: MR imaging measurements of LGN height and volume are diminished in patients with glaucoma, with the extent of atrophy correlating to clinical stage, suggesting a novel imaging marker of disease severity.Keywords
This publication has 15 references indexed in Scilit:
- Morphological changes in the visual pathway induced by experimental glaucoma in Japanese monkeysExperimental Eye Research, 2009
- Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imagingBritish Journal of Ophthalmology, 2008
- Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brainExperimental Eye Research, 2007
- Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortexBritish Journal of Ophthalmology, 2006
- The number of people with glaucoma worldwide in 2010 and 2020British Journal of Ophthalmology, 2006
- Categorizing the Stage of Glaucoma From Pre-Diagnosis to End-Stage DiseaseAmerican Journal of Ophthalmology, 2006
- Oxidative injury by peroxynitrite in neural and vascular tissue of the lateral geniculate nucleus in experimental glaucomaExperimental Eye Research, 2005
- Primary open-angle glaucomaThe Lancet, 2004
- Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucomaProgress in Retinal and Eye Research, 2003
- Loss of Neurons in Magnocellular and Parvocellular Layers of the Lateral Geniculate Nucleus in GlaucomaArchives of Ophthalmology (1950), 2000